Innovate
the way
we see life
Welcome to Tomocube,
where we lead the way in
Holotomography technology
Rooted in our mission, we strive to empower scientists and researchers with cutting-edge imaging tools, fostering groundbreaking discoveries that redefine the limits of what's possible.
Building on the remarkable success of our award-winning HT-series, we persistently develop the next generation of HT microscopes. A key strength of Tomocube lies in its comprehensive in-house capabilities spanning hardware, software, firmware, mechanical design, optics design, and AI development for our Holotomography imaging and analysis solution. This all-encompassing expertise facilitates integration and innovation in our products.
At Tomocube, our unwavering dedication to scientific innovation propels us to consistently push the boundaries of what is possible. Guided by our philosophy, "Innovate the way we see life", we embrace a culture of continuous exploration and evolution. This commitment to scientific innovation is not just a mission but a driving force behind our contributions to the understanding, diagnosis, and treatment of diseases. Through the provision of cutting-edge HT-based imaging tools and medical equipment, we actively contribute to advancements that have a lasting impact on the lives of people worldwide.
All the members at Tomocube envision a future where our hard work changes the world, making technology that improves lives.
-
- 2015.08
- Tomocube Established
-
- 2016.04
- HT-1H Launching
-
- 2017.11
- ISO 9001, 14001 Certification
-
- 2017.12
- HT-2H Launching
-
- 2021.09
- Completed Series C funding
-
- 2022.07
- HT-X1 Launching
-
- 2023.11
- HT-Ready 96 Well Plate Launching
-
- 2023.12
- TomoAnalysis Launching
-
- 2024.10
- HT-X1 Plus launching
-
- 2024.11
- Listed on KOSDAQ
Leadership
-
YongKeun (Paul) Park
Chief Executive OfficerYongKeun (Paul) Park is an Endowed Chair Professor of Physics at KAIST (Korea Advanced Institute of Science and Technology). He earned a Ph.D. in Medical Science and Engineering from Harvard-MIT Health Science and Technology. Dr. Park’s area of research is optics, holography, and biophotonics. He has published over 200 peer-reviewed papers with >16K citations, including 4 Nat Photon, 1 Nat Mat, 1 Nat Cell Biol, 1 Nat Method, 4 Nat Comm, 4 PRL, and 6 PNAS papers. He is a Fellow of the Optical Society of America (OSA) and the Society of Photo-Optical Instrumentation Engineers (SPIE). He received Medals of Honor in Science and Technology (President of South Korea) and the Jinki Hong Creative Award.
-
Kihyun (Kenny) Hong
Chief Executive OfficerKihyun (Kenny) Hong co-founded Tomocube in 2015 and has served as CEO since then. He is a serial entrepreneur with 25 years of experience in industrial optical inspection/measurement business and startup investment. Previously, he founded Akcron Inc. and Wiseplanet Inc., both of which achieved successful exits in 2002 and 2012 respectively. Prior to co-founding Tomocube, Kihyun worked at Bluepoint Partners, a leading accelerator, as founding partners. He graduated from KAIST in 1996 with a major in Industrial and Management.
-
SungHo Ko
Chief Operation OfficerSungHo has more than 20 years of experience in the medical device industry, including diagnostic imaging devices and therapeutic energy devices. His experience ranges from product management to quality assurance. He graduated from KAIST with an MS degree in Industrial Engineering.
-
Kyungtae Oh
Chief Financial OfficerKyungtae Oh has two decades of experience leading financial operations for public and private companies. Before joining Tomocube, he served as Chief Financial Officer at Engis Technologies, where he led a successful initial public offering (IPO). He graduated from Sogang University with a BS degree in Economics.